
AstraZeneca today announced that it has completed the divestment of the global rights to ...

BRIDGEWATER, N.J., June 12, 2017 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX) today announced ...

-- First Clinical Trial to Test the Safety and Activity of Activated Allogeneic Donor ...
Click to continue to site. Closing